Regulation of Biological Product/Drug Development: An Introduction A session from FDLI's FDLI’s Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More Recorded March 5–6, 2024 Regulation of Biological Product/Drug Development: An Introduction Summarize preclinical and clinical testing, sources of Good Clinical Practice [...]
Introduction to FDA Review and Approval of Biological Products A session from FDLI's Introduction to Biological Products, Including Vaccines, Biosimilars, Cell and Gene Therapies, and Other Advanced Therapies Recorded March 5–6, 2024 Introduction to FDA Review and Approval of Biological Products Learn the statutory [...]
Overview of Biological Products Law and FDA’s Regulatory Processes A session from FDLI's Introduction to Biologics: Vaccines, Biosimilars, Cell and Gene Therapies, and More Recorded February 27, 2024 Overview of Biological Products Law and FDA’s Regulatory Processes Learn about the role of the Food [...]
Food and Dietary Supplement Safety and Regulation Conference April 3, 2024 Washington, DC In-Person & Virtual Event Overview Agenda Details Agenda Agenda Subject to Change All Times Listed in Eastern Time Wednesday, April 3 FDLI Welcome Christine M. Simmon, President [...]
2024 FDLI Annual Conference May 15–16, 2024 Washington, DC In-Person & Virtual Event Overview Agenda Details Agenda Agenda Subject to Change All Times Listed in Eastern Time Wednesday, May 15 Christine M. Simmon, President & CEO, FDLI Winston S. Kirton, [...]
Advertising & Promotion for Medical Products Conference October 17–18, 2024 In-Person & Virtual Event Overview Agenda Details Continuing Legal Education Location and Overnight Accommodations Location The Westin Washington, DC Downtown 999 9th Street Northwest Washington, DC [...]
Advertising & Promotion for Medical Products Conference October 17–18, 2024 In-Person & Virtual Event Overview Agenda Details Agenda Subject to Change All Times Are Eastern Standard Time To view the session description, please click on the session title. Thursday, October 17 [...]
FDLI Board of Directors Conflict of Interest Policy The Board of Directors of FDLI (“the Food and Drug Law Institute” or “the Institute”) has adopted the following policy in order to avoid or manage possible conflicts of interest on the part of FDLI Board Members when acting on behalf of the Institute. Preamble A [...]
Topic Suggestions Is there a specific topic you would like to see addressed in a future FDLI event? If so, please share your suggestions on our online portal.
Topic Suggestions Is there a specific topic you would like to see addressed in a future FDLI event? If so, please share your suggestions on our online portal.
